These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 23514959

  • 21. De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability.
    Kauke T, Oberhauser C, Lin V, Coenen M, Fischereder M, Dick A, Schoenermarck U, Guba M, Andrassy J, Werner J, Meiser B, Angele M, Stangl M, Habicht A.
    Transpl Int; 2017 Apr; 30(4):360-370. PubMed ID: 27862352
    [Abstract] [Full Text] [Related]

  • 22. Terasaki Epitope Mismatch Burden Predicts the Development of De Novo DQ Donor-Specific Antibodies and are Associated With Adverse Allograft Outcomes.
    Willicombe M, Blow M, Santos-Nunez E, Freeman C, Brookes P, Taube D.
    Transplantation; 2018 Jan; 102(1):127-134. PubMed ID: 28731902
    [Abstract] [Full Text] [Related]

  • 23. The role of complement-fixing donor-specific antibodies identified by a C1q assay after heart transplantation.
    Farrero Torres M, Pando MJ, Luo C, Luikart H, Valantine H, Khush K.
    Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28940521
    [Abstract] [Full Text] [Related]

  • 24. C1q-binding DSA and allograft outcomes in pediatric kidney transplant recipients.
    Hayde N, Solomon S, Caglar E, Ge J, Qama E, Colovai A.
    Pediatr Transplant; 2021 Mar; 25(2):e13885. PubMed ID: 33131194
    [Abstract] [Full Text] [Related]

  • 25. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
    Okabe Y, Noguchi H, Miyamoto K, Kaku K, Tsuchimoto A, Masutani K, Nakamura M.
    Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221
    [Abstract] [Full Text] [Related]

  • 26. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
    Ho EK, Vlad G, Vasilescu ER, de la Torre L, Colovai AI, Burke E, Deng M, Schwartz J, Marboe C, Mancini D, Opelz G, Suciu-Foca N.
    Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
    [Abstract] [Full Text] [Related]

  • 27. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011 Jan; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 28. Role of Pretransplant Complement-fixing Donor-specific Antibodies Identified by C1q Assay in Kidney Transplantation.
    Thammanichanond D, Wiwattanathum P, Mongkolsuk T, Kantachuvesiri S, Worawichawong S, Vallipakorn SA, Kitpoka P.
    Transplant Proc; 2016 Apr; 48(3):756-60. PubMed ID: 27234729
    [Abstract] [Full Text] [Related]

  • 29. Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss.
    Sutherland SM, Chen G, Sequeira FA, Lou CD, Alexander SR, Tyan DB.
    Pediatr Transplant; 2012 Feb; 16(1):12-7. PubMed ID: 22093755
    [Abstract] [Full Text] [Related]

  • 30. Eplet Mismatch Load and De Novo Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study.
    Senev A, Coemans M, Lerut E, Van Sandt V, Kerkhofs J, Daniëls L, Driessche MV, Compernolle V, Sprangers B, Van Loon E, Callemeyn J, Claas F, Tambur AR, Verbeke G, Kuypers D, Emonds MP, Naesens M.
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [Abstract] [Full Text] [Related]

  • 31. Significant association between chronic antibody-mediated rejection and donor-specific antibodies against HLA-DRB rather than DQB in renal transplantation.
    Kobayashi T, Maruya E, Niwa M, Saji H, Kohara S, Katayama A, Takeda A, Watarai Y, Uchida K.
    Hum Immunol; 2011 Jan; 72(1):11-7. PubMed ID: 20974206
    [Abstract] [Full Text] [Related]

  • 32. Association of C1q Binding Status With De Novo HLA Antibody Clinical Features and Allograft Function in Kidney Transplantation Patients During Eight Years of Dynamic Follow-up.
    Wei X, Yuan X, Sun M, Pan Z, Hu L, Wang L, He J, Hou J.
    Transplant Proc; 2016 Jan; 48(6):1944-54. PubMed ID: 27569927
    [Abstract] [Full Text] [Related]

  • 33. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 34. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A, Crespo Albiach J, Montoro JA, Pallardo Mateu LM.
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [Abstract] [Full Text] [Related]

  • 35. Complement-fixing donor-specific anti-HLA antibodies and kidney allograft failure.
    Cazarote HB, Shimakura S, Valdameri JS, Contieri FLC, von Glehn CQC, Aita CM, Susin MF, Sotomaior VS, Glehn-Ponsirenas R.
    Transpl Immunol; 2018 Aug; 49():33-38. PubMed ID: 29596992
    [Abstract] [Full Text] [Related]

  • 36. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X, Ishida H, Yamaguchi Y, Tanabe K.
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [Abstract] [Full Text] [Related]

  • 37. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations.
    Dieplinger G, Ditt V, Arns W, Huppertz A, Kisner T, Hellmich M, Bauerfeind U, Stippel DL.
    Transpl Int; 2014 Jan; 27(1):60-8. PubMed ID: 24131087
    [Abstract] [Full Text] [Related]

  • 38. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM, Gaber AO, Knight RJ, Land GA, Suki WN, Gaber LW, Patel SJ.
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [Abstract] [Full Text] [Related]

  • 39. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P, Canbakan M, Kara M, Özel L, Ünal E, Titiz Mİ.
    Transplant Proc; 2012 Sep; 44(6):1652-5. PubMed ID: 22841237
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.